Klotho Neurosciences, Inc.
KLTO
$0.1748
-$0.0069-3.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1,534.23% | -1,953.71% | -70.80% | -289.57% | -21.75% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 914.20% | 1,811.80% | -- | -- | -- |
| Change in Net Operating Assets | 1,044.07% | -140.90% | -408.08% | 3,322.64% | 6,650.00% |
| Cash from Operations | -373.28% | -6,061.11% | -776.71% | 86.41% | -92.94% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 100.00% | 100.00% | -1,135.00% | 301.20% |
| Cash from Investing | -100.00% | 100.00% | 100.00% | -1,135.00% | 301.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 857.00% | -- | -- | -30.00% | 140.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,728.57% | -1,974.15% | 816.30% | -62.23% | 100.17% |